Related Experiment Video
Updated: Aug 22, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes
Rial A Christensen1, Alexander Shtifman, Paul D Allen
1Department of Neurology, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, 736 Cambridge St., Boston, MA 02135, USA.
Abstract:
The relative scarcity of inclusion-affected muscle cells or markers of cell death in inclusion body myositis (IBM) is in distinction to the specific and early intracellular deposition of several Alzheimer's Disease (AD)-related proteins. The current study examined the possible correlation between myotube beta-amyloid and/or Tau accumulations and a widespread mishandling of intracellular muscle calcium concentration that could potentially account for the unrelenting weakness in affected patients. Cultured myogenic cells (C(2)C(12)) expressed beta-amyloid-42 (Abeta(42)) and fetal Tau peptides, as human transgenes encoded by herpes simplex virus, either individually or concurrently. Co-expression of Abeta(42) in C(2)C(12) myotubes resulted in hyperphosphorylation of Tau protein that was not observed when Tau was expressed alone. Resting calcium concentration and agonist-induced RyR-mediated Ca(2+) release were examined using calcium-specific microelectrodes and Fluo-4 epifluorescence, respectively. Co-expression of Abeta(42) and Tau cooperatively elevated basal levels of myoplasmic-free calcium, an effect that was accompanied by depolarization of the plasma membrane. Sarcoplasmic reticulum (SR) calcium release, induced by KCl depolarization, was not affected by Abeta(42) or Tau. In contrast, expression of Abeta(42), Tau, or Abeta(42) together with Tau resulted in enhanced sensitivity of ryanodine receptors to activation by caffeine. Notably, expression of beta-amyloid, alone, was sufficient to result in an increased sensitivity to direct activation by caffeine. Current results indicate that amyloid proteins cooperate to raise resting calcium levels and that these effects are associated with a passive SR Ca(2+) leak and Tau hyperphosphorylation in skeletal muscle.
Insights
Alzheimer's Disease proteins, beta-amyloid and Tau, disrupt muscle calcium regulation and cause Tau hyperphosphorylation in inclusion body myositis. This study reveals how these proteins contribute to muscle weakness by affecting calcium handling.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Inclusion Body Myositis (IBM) shows few dying muscle cells, unlike Alzheimer's Disease (AD) which has early protein deposits.
- The study investigates the link between beta-amyloid and Tau accumulation in muscle cells and calcium mishandling in IBM patients.
Purpose of the Study:
- To examine the correlation between myotube beta-amyloid and/or Tau accumulations and intracellular muscle calcium concentration.
- To understand the mechanism behind muscle weakness in IBM patients.
Main Methods:
- Cultured myogenic cells (C(2)C(12)) were engineered to express beta-amyloid-42 (Abeta(42)) and fetal Tau peptides.
- Calcium levels were measured using calcium-specific microelectrodes and Fluo-4 epifluorescence.
- Ryanodine receptor sensitivity to calcium release was assessed.
Main Results:
- Co-expression of Abeta(42) and Tau led to Tau hyperphosphorylation.
- Combined Abeta(42) and Tau expression increased basal myoplasmic-free calcium levels and plasma membrane depolarization.
- Abeta(42) or Tau expression, individually or together, enhanced ryanodine receptor sensitivity to caffeine, indicating altered calcium release.
- Beta-amyloid expression alone increased sensitivity to caffeine.
Conclusions:
- Amyloid proteins synergistically elevate resting calcium levels in muscle cells.
- These effects are linked to passive sarcoplasmic reticulum (SR) calcium leak and Tau hyperphosphorylation.
- The findings suggest a novel mechanism contributing to muscle weakness in IBM.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Skeleton and Calcium Homeostasis

